’The need for better therapeutic options for brain cancers is very big’

By Anders [dot] Martensson [at] med [dot] lu [dot] se (Anders Mårtensson) - published 15 June 2022

Wallenberg Molecular Medicine Clinical Researcher - Anders Wittrup

The focus of oncologist Anders Wittrup’s research is so called RNA therapeutics and how it can be developed into cancer therapies. “We have a special focus on brain cancers for which there today are very poor treatment options.”

Anders Wittrup is a resident in oncology at Skåne University Hospital and a researcher at Wallenberg Centre for Molecular Medicine (WCMM). In 2022, every week a researcher working at WCMM at Lund University and Skåne University Hospital is presented. In the video, Anders Wittrup shares more about his research.

About Wallenberg Centre for Molecular Medicine 
 

Wallenberg Centre for Molecular Medicine (WCMM) is a research centre focused on Regenerative and Translational Medicine.
Through integrated research environments and excellent infrastructure, conditions are created for world-leading molecular and translational research.
   
The research at the Wallenberg Centre for Molecular Medicine was made possible by generous funding from the Knut and Alice Wallenberg Foundation, the Region Skåne and the Faculty of Medicine at Lund University. The Knut and Alice Wallenberg Foundation is making a nationwide effort to ensure that Sweden regains a world-leading position in medical research.